The effects of budesonide on angiogenesis in a murine asthma model

Archives of Medical Science

Volumn 9, Issue 2, 2013, Pages 361-367

  Sun, Yan ^a   Wang, Jinrong ^a   Li, Huabing ^b   Sun, Lifeng ^a   Wang, Yulin ^a   Han, Xiuzhen ^a  

^a SHANDONG UNIVERSITY   (China)

^b Zhucheng People's Hospital   (China)

Author keywords

Angiogenesis; Asthma; Budesonide; Hypoxia inducible factor 1 ; Vascular endothelial growth factor

Indexed keywords

BUDESONIDE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; VASCULOTROPIN;

AIRWAY REMODELING; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; ASTHMA; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RESPIRATORY TRACT INFLAMMATION; VASCULARIZATION; WESTERN BLOTTING;

EID: 84876901058     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2013.33194     Document Type: Article

References (29)

1. Royce SG, Tang ML. The effects of current therapies on airway remodeling in asthma and new possibilities for treatment and prevention.Curr Mol Pharmacol 2009; 2: 169-81.
2. Żukiewicz-Sobczak W, Krasowska E, Zwoliñski J, et al. Allergic diseases - current state of knowledge. Postep Derm Alergol 2012; 29: 451-5.
3. Detoraki A, Granata F, Staibano S, Rossi FW, Marone G, Genovese A. Angiogenesis and lymphangiogenesis in bronchial asthma. Allergy 2010; 65: 946-58.
4. Radwan ZM, Yamamah GA, Shaaban HH, Abdel-Rahman AM, Ismaeil AA, Mostafa EM. Effect of different monotherapies on serum nitric oxide and pulmonary functions in children with mild persistent asthma. Arch Med Sci 2010; 6: 919-25.
5. De Bosscher K, Vanden Berghe W, Haegeman G. The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression. Endocr Rev 2003; 24: 488-522. (Pubitemid 37059110)
6. Adcock IM, Ito K, Barnes PJ.Glucocorticoid: effects on gene transcription. Proc Am Thorac Soc 2004; 1: 247-54.
7. Oleś D, Szczepankiewicz A, Wołuń-Cholewa M, et al. Does concentration influence viability of the bronchial epithelial cell line chronically exposed to antiasthmatic drugs? Postep Derm Alergol 2012; 29: 363-8.
8. Chanez P, Bourdin A, Vachier I, Godard P, Bousquet J, Vignola AM. Effects of inhaled corticosteroids on pathology in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 2004; 1: 184-90.
9. Horvath G, Wanner A. Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma. Eur Respir J 2006; 27: 172-87. (Pubitemid 43092682)
10. Baluk P, Lee CG, Link H, et al. Regulated angiogenesis and vascular regression in mice overexpressing vascular endothelial growth factor in airways. Am J Pathol 2004; 165: 1071-85. (Pubitemid 39297715)
11. Lee SY, Kwon S, Kim KH, et al. Expression of vascular endothelial growth factor and hypoxia-inducible factor in the airway of asthmatic patients. Ann Allergy Asthma Immunol 2006; 97: 794-9. (Pubitemid 46032432)
12. Jaakkola P, Mole DR, Tian YM, et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 2001; 292: 468-72. (Pubitemid 32335942)
13. Kaelin WG Jr. How oxygen makes its presence felt. Genes Dev 2002; 16: 1441-5.
14. Ivan M, Kondo K, Yang H, et al. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 2001; 292: 464-8. (Pubitemid 32335941)
15. Lan F, Liu K, Zhang J, Qi Y, Li K, Lin P. Th17 response is augmented in OVA-induced asthmatic mice exposed to HDM. Med Sci Monit 2011; 17: 132-8.
16. Cho JY, Miller M, Baek KJ, et al. Immunostimulatory DNA sequences inhibit respiratory syncytial viral load, airway inflammation, and mucus secretion. J Allergy Clin Immunol 2001; 108: 697-702. (Pubitemid 33096197)
17. Fukushima C, Matsuse H, Fukahori S, et al. Aspergillus fumigatus synergis tically enhances mite-induced allergic airway inflammation. Med Sci Monit 2010; 16: 197-202.
18. Hoshino M, Aoike N, Takahashi M, Nakamura Y, Nakagawa T. Increased immunoreactivity of stromal cell-derived factor-1 and angiogenesis in asthma. Eur Respir J 2003; 21: 804-9. (Pubitemid 36592289)
19. Salvato G. Quantitative and morphological analysis of the vascular bed in bronchial biopsy specimens from asthmatic and non-asthmatic subjects. Thorax 2001; 56: 902-6. (Pubitemid 33097183)
20. Tanaka H, Yamada G, Saikai T, et al. Increased airway vascularity in newly diagnosed asthma using a high-magnification bronchovideoscope. Am J Respir Crit Care Med 2003; 168: 1495-9. (Pubitemid 38037335)
21. Yuksel H, Kose C, Yilmaz O, et al. Increased expression of tissue vascular endothelial growth factor and foetal liver kinase-1 receptor in seasonal allergic rhinitis and relevance to asthma component. Clin Exp Allergy 2007; 37: 1183-8. (Pubitemid 47076346)
22. Feltis BN, Wignarajah D, Zheng L, et al. Increased vascular endothelial growth factor and receptors: relationship to angiogenesis in asthma. Am J Respir Crit Care Med 2006; 173: 1201-7. (Pubitemid 43848389)
23. Boddy JL, Fox SB, Han C, et al. The androgen receptor is significantly associated with vascular endothelial growth factor and hypoxia sensing via hypoxia-inducible factors HIF-1a, HIF-2a, and the prolyl hydroxylases in human prostate cancer. Clin Cancer Res 2005; 11: 7658-63. (Pubitemid 41611607)
24. Fukushima K, Murata M, Hachisuga M, et al. Hypoxia inducible factor 1 alpha regulates matrigel-induced endovascular differentiation under normoxia in a human extravillous trophoblast cell line. Placenta 2008; 29: 324-31.
25. Tsuzuki Y, Fukumura D, Oosthuyse B, Koike C, Carmeliet P, Jain RK. Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1alpha -> hypoxia response element -> VEGF cascade differentially regulates vascular response and growth rate in tumors. Cancer Res 2000; 60: 6248-52.
26. Kelly BD, Hackett SF, Hirota K, et al. Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res 2003; 93: 1074-81. (Pubitemid 37485038)
27. Yu AY, Shimoda LA, Iyer NV, et al. Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1alpha. J Clin Invest 1999; 103: 691-6. (Pubitemid 29122422)
28. Bandi N, Kompella UB. Budesonide reduces vascular endothelial growth factor secretion and expression in airway (Calu-1) and alveolar (A549) epithelial cells. Eur J Pharmacol 2001; 425: 109-16. (Pubitemid 32739155)
29. Mathew J, Aronow WS, Chandy D. Therapeutic options for severe asthma. Arch Med Sci 2012; 8: 589-97.